<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Pathog</journal-id><journal-id journal-id-type="iso-abbrev">PLoS Pathog</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plospath</journal-id><journal-title-group><journal-title>PLoS Pathogens</journal-title></journal-title-group><issn pub-type="ppub">1553-7366</issn><issn pub-type="epub">1553-7374</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5373618</article-id><article-id pub-id-type="pmid">28358867</article-id><article-id pub-id-type="doi">10.1371/journal.ppat.1006209</article-id><article-id pub-id-type="publisher-id">PPATHOGENS-D-16-02872</article-id><article-categories><subj-group subj-group-type="heading"><subject>Pearls</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Fungal Pathogens</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Fungal Pathogens</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Mycology</subject><subj-group><subject>Fungal Pathogens</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Fungal Genetics</subject><subj-group><subject>Fungal Genomics</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Mycology</subject><subj-group><subject>Fungal Genetics</subject><subj-group><subject>Fungal Genomics</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Genomics</subject><subj-group><subject>Fungal Genomics</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biotechnology</subject><subj-group><subject>Bioengineering</subject><subj-group><subject>Synthetic Bioengineering</subject><subj-group><subject>Genome Engineering</subject><subj-group><subject>Synthetic Genome Editing</subject><subj-group><subject>Crispr</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Engineering and Technology</subject><subj-group><subject>Bioengineering</subject><subj-group><subject>Synthetic Bioengineering</subject><subj-group><subject>Genome Engineering</subject><subj-group><subject>Synthetic Genome Editing</subject><subj-group><subject>Crispr</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Synthetic Biology</subject><subj-group><subject>Synthetic Bioengineering</subject><subj-group><subject>Genome Engineering</subject><subj-group><subject>Synthetic Genome Editing</subject><subj-group><subject>Crispr</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Engineering and Technology</subject><subj-group><subject>Synthetic Biology</subject><subj-group><subject>Synthetic Bioengineering</subject><subj-group><subject>Genome Engineering</subject><subj-group><subject>Synthetic Genome Editing</subject><subj-group><subject>Crispr</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Synthetic Biology</subject><subj-group><subject>Synthetic Genomics</subject><subj-group><subject>Synthetic Genome Editing</subject><subj-group><subject>Crispr</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Engineering and Technology</subject><subj-group><subject>Synthetic Biology</subject><subj-group><subject>Synthetic Genomics</subject><subj-group><subject>Synthetic Genome Editing</subject><subj-group><subject>Crispr</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Genomics</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Fungal Genetics</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Mycology</subject><subj-group><subject>Fungal Genetics</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Fungi</subject><subj-group><subject>Molds (Fungi)</subject><subj-group><subject>Aspergillus</subject><subj-group><subject>Aspergillus Fumigatus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Fungal Pathogens</subject><subj-group><subject>Aspergillus Fumigatus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Fungal Pathogens</subject><subj-group><subject>Aspergillus Fumigatus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Mycology</subject><subj-group><subject>Fungal Pathogens</subject><subj-group><subject>Aspergillus Fumigatus</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Fungi</subject><subj-group><subject>Cryptococcus</subject><subj-group><subject>Cryptococcus Neoformans</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Fungal Pathogens</subject><subj-group><subject>Cryptococcus Neoformans</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Fungal Pathogens</subject><subj-group><subject>Cryptococcus Neoformans</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Mycology</subject><subj-group><subject>Fungal Pathogens</subject><subj-group><subject>Cryptococcus Neoformans</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Mutation</subject><subj-group><subject>Insertion Mutation</subject></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Location, location, location: Use of CRISPR-Cas9 for genome editing in human pathogenic fungi</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-0868-4000</contrib-id><name><surname>Mitchell</surname><given-names>Aaron P.</given-names></name><xref ref-type="corresp" rid="cor001">*</xref><xref ref-type="aff" rid="aff001"/></contrib></contrib-group><aff id="aff001"><addr-line>Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, Pennsylvania, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Sheppard</surname><given-names>Donald C</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>McGill University, CANADA</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>apm1@cmu.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>30</day><month>3</month><year>2017</year></pub-date><pub-date pub-type="collection"><month>3</month><year>2017</year></pub-date><volume>13</volume><issue>3</issue><elocation-id>e1006209</elocation-id><permissions><copyright-statement>&#x000a9; 2017 Aaron P. Mitchell</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Aaron P. Mitchell</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="ppat.1006209.pdf"/><funding-group><funding-statement>This work was supported by NIH grant 1R01AI124566. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="1"/><table-count count="0"/><page-count count="5"/></counts></article-meta></front><body><p>Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)-Cas9 systems enable the targeting of a double-strand break in genomic DNA to a location chosen by the investigator [<xref rid="ppat.1006209.ref001" ref-type="bibr">1</xref>]. The break may be repaired (<xref ref-type="fig" rid="ppat.1006209.g001">Fig 1</xref>) by cellular nonhomologous end joining (NHEJ) machinery to yield small insertions and deletions [<xref rid="ppat.1006209.ref002" ref-type="bibr">2</xref>], which are often loss-of-function mutations in coding regions. If a repair template that spans the break site is available, the break may be repaired by cellular homology-dependent repair (HR) machinery to create a precisely designed insertion, deletion, gene or promoter fusion, or base substitution [<xref rid="ppat.1006209.ref002" ref-type="bibr">2</xref>]. CRISPR-Cas9 systems can be programmed to define the location of a break; hence, an investigator can determine the location of a targeted mutation (<xref ref-type="fig" rid="ppat.1006209.g001">Fig 1</xref>). This technology has revolutionized genetic manipulation of model organisms, cell lines, animals, plants, and even human embryos [<xref rid="ppat.1006209.ref001" ref-type="bibr">1</xref>]. The technology has been adapted for use in a variety of fungi (reviewed in [<xref rid="ppat.1006209.ref003" ref-type="bibr">3</xref>]), including <italic>Saccharomyces cerevisiae</italic> [<xref rid="ppat.1006209.ref004" ref-type="bibr">4</xref>] and multiple <italic>Aspergillus</italic> species of agricultural and industrial importance [<xref rid="ppat.1006209.ref005" ref-type="bibr">5</xref>]. Among human fungal pathogens, CRISPR-Cas9 genome editing has been applied successfully to <italic>Aspergillus fumigatus</italic> [<xref rid="ppat.1006209.ref006" ref-type="bibr">6</xref>,<xref rid="ppat.1006209.ref007" ref-type="bibr">7</xref>], <italic>Cryptococcus neoformans var</italic>. <italic>neoformans</italic> [<xref rid="ppat.1006209.ref008" ref-type="bibr">8</xref>], <italic>C</italic>. <italic>neoformans var</italic>. <italic>grubii</italic> [<xref rid="ppat.1006209.ref009" ref-type="bibr">9</xref>], <italic>Candida albicans</italic> [<xref rid="ppat.1006209.ref010" ref-type="bibr">10</xref>,<xref rid="ppat.1006209.ref011" ref-type="bibr">11</xref>], and <italic>Ca</italic>. <italic>glabrata</italic> [<xref rid="ppat.1006209.ref012" ref-type="bibr">12</xref>]. In these organisms, CRISPR-Cas9 systems have accelerated the creation of gene-targeted mutations, often without selection for the mutant phenotype, and have enabled the modification of multiple genes or alleles in a single transformation.</p><fig id="ppat.1006209.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1006209.g001</object-id><label>Fig 1</label><caption><title>Outcomes of Cas9-single guide RNA (sgRNA) cleavage at a genomic site.</title><p>The Cas9-sgRNA complex is able to target a double-strand break in DNA to a specific site in the genome. The break is repaired by cellular machinery to generate a mutation that alters the site, thus preventing repeated cleavage. If the cell has a template that has homology to both sides of the break (left side of panel), then the template can be used by homology-dependent repair. For genome engineering, the investigator introduces into cells a custom template along with sources of Cas9 and the relevant sgRNA to create a designer mutation. Such mutations may be small changes in nucleotide sequence or a large insertion or deletion. Alternatively, the cell can use nonhomologous end joining (right side of panel) to create small insertions or deletions at the cut site.</p></caption><graphic xlink:href="ppat.1006209.g001"/></fig><sec id="sec001"><title>CRISPR-Cas9 components</title><p>The nuclease that creates double-strand breaks has two components: the Cas9 protein and a single guide RNA (sgRNA) [<xref rid="ppat.1006209.ref001" ref-type="bibr">1</xref>]. The commonly used <italic>CAS9</italic> gene originated in <italic>Streptococcus pyogenes</italic>, and it has been modified for use in eukaryotic cells through inclusion of gene segments for a nuclear localization sequence and, in many cases, an epitope tag. <italic>CAS9</italic> genes used in most fungi come from versions that were codon-optimized for human cells [<xref rid="ppat.1006209.ref006" ref-type="bibr">6</xref>,<xref rid="ppat.1006209.ref007" ref-type="bibr">7</xref>,<xref rid="ppat.1006209.ref008" ref-type="bibr">8</xref>,<xref rid="ppat.1006209.ref009" ref-type="bibr">9</xref>,<xref rid="ppat.1006209.ref011" ref-type="bibr">11</xref>,<xref rid="ppat.1006209.ref012" ref-type="bibr">12</xref>]; the <italic>CAS9</italic> gene used in <italic>Ca</italic>. <italic>albicans</italic> was modified to accommodate the species' variant genetic code [<xref rid="ppat.1006209.ref011" ref-type="bibr">11</xref>]. In all described human fungal pathogen Cas9 systems, the modified <italic>CAS9</italic> gene is expressed constitutively from a fungal RNA polymerase II promoter [<xref rid="ppat.1006209.ref006" ref-type="bibr">6</xref>,<xref rid="ppat.1006209.ref007" ref-type="bibr">7</xref>,<xref rid="ppat.1006209.ref008" ref-type="bibr">8</xref>,<xref rid="ppat.1006209.ref009" ref-type="bibr">9</xref>,<xref rid="ppat.1006209.ref011" ref-type="bibr">11</xref>,<xref rid="ppat.1006209.ref012" ref-type="bibr">12</xref>].</p><p>Cas9 associates with the sgRNA, whose sequence directs DNA cleavage through base-pairing with one strand of the target DNA [<xref rid="ppat.1006209.ref001" ref-type="bibr">1</xref>]. The sgRNAs that are used in most genome editing systems derive from an engineered fusion of the two natural Cas9-associated RNAs, the CRISPR RNA (crRNA) and the transactivating CRISPR RNA (tracrRNA) [<xref rid="ppat.1006209.ref001" ref-type="bibr">1</xref>]. The sgRNA must be uncapped for function. In the described human fungal pathogen systems, the uncapped sgRNA is often expressed from an RNA polymerase III promoter [<xref rid="ppat.1006209.ref006" ref-type="bibr">6</xref>,<xref rid="ppat.1006209.ref007" ref-type="bibr">7</xref>,<xref rid="ppat.1006209.ref008" ref-type="bibr">8</xref>,<xref rid="ppat.1006209.ref011" ref-type="bibr">11</xref>,<xref rid="ppat.1006209.ref012" ref-type="bibr">12</xref>]. This expression strategy imposes the constraint that the 5&#x02032; sgRNA residue must be G, which, in most systems, precedes the targeting region of the sgRNA. If the G is included in the targeting region, this constraint may limit the number of accessible target sites, though it has been argued that a one base-pair mismatch at the 5&#x02032; sgRNA residue may have little impact [<xref rid="ppat.1006209.ref013" ref-type="bibr">13</xref>]. A second expression strategy was implemented by Arras et al. [<xref rid="ppat.1006209.ref009" ref-type="bibr">9</xref>], who took inspiration from plant genome editing systems [<xref rid="ppat.1006209.ref014" ref-type="bibr">14</xref>], in which sgRNA is produced via flanking self-cleaving ribozyme sequences after expression from an RNA polymerase II promoter. Finally, it should be noted that in vitro-synthesized sgRNA, included in the transformation mix, has been shown to function in <italic>A</italic>. <italic>fumigatus</italic> [<xref rid="ppat.1006209.ref007" ref-type="bibr">7</xref>].</p></sec><sec id="sec002"><title>Introduction of CRISPR-Cas9 components into cells</title><p>In many systems, the Cas9 and sgRNA genes are carried on one or two cassettes that are integrated into a genomic site or, if the organism permits, present on plasmids. One generally useful approach is to first create a strain that expresses Cas9, then follow up with a second transformation that introduces an sgRNA gene or in vitro-synthesized sgRNA and, if desired, a repair template [<xref rid="ppat.1006209.ref006" ref-type="bibr">6</xref>,<xref rid="ppat.1006209.ref007" ref-type="bibr">7</xref>,<xref rid="ppat.1006209.ref009" ref-type="bibr">9</xref>,<xref rid="ppat.1006209.ref011" ref-type="bibr">11</xref>,<xref rid="ppat.1006209.ref012" ref-type="bibr">12</xref>]. It has been demonstrated rigorously that Cas9 expression is innocuous in <italic>A</italic>. <italic>fumigatus</italic>, <italic>Ca</italic>. <italic>albicans</italic>, and <italic>C</italic>. <italic>neoformans</italic> [<xref rid="ppat.1006209.ref006" ref-type="bibr">6</xref>,<xref rid="ppat.1006209.ref009" ref-type="bibr">9</xref>,<xref rid="ppat.1006209.ref011" ref-type="bibr">11</xref>]. A single Cas9-expressing strain can thus be used to create mutations in diverse genes that are determined by the choice of sgRNA and repair template.</p><p>The Cas9-sgRNA complex is needed only transiently to create a recombinogenic/mutagenic double-strand break [<xref rid="ppat.1006209.ref001" ref-type="bibr">1</xref>]. In fact, there are cases in which Cas9 expression affects growth or virulence [<xref rid="ppat.1006209.ref008" ref-type="bibr">8</xref>,<xref rid="ppat.1006209.ref012" ref-type="bibr">12</xref>], in contrast to those situations mentioned above. Hence, it may be important to eliminate the source of Cas9 for phenotypic analysis of a newly generated mutant. This problem has been solved by creating situations in which the genes specifying Cas9 and sgRNAs are present only transiently in recipient cells. One solution, applied to <italic>C</italic>. <italic>neoformans</italic> [<xref rid="ppat.1006209.ref008" ref-type="bibr">8</xref>], was an elegant modification of the Capecchi homology-directed gene knockout construct for mice [<xref rid="ppat.1006209.ref015" ref-type="bibr">15</xref>]. The repair template had appended, at one end, the genes specifying Cas9 and the sgRNA [<xref rid="ppat.1006209.ref008" ref-type="bibr">8</xref>]. The idea was that homologous recombination at both sides of the genomic cut site would yield an isolated linear DNA segment specifying Cas9 and the sgRNA, which would be degraded and lost [<xref rid="ppat.1006209.ref008" ref-type="bibr">8</xref>]. A second solution, applied to <italic>C</italic>. <italic>albicans</italic>, came from the observation that many Cas9-sgRNA&#x02014;directed deletion/insertion mutants did not carry integrated copies of the genes specifying the sgRNA and Cas9 [<xref rid="ppat.1006209.ref010" ref-type="bibr">10</xref>]. In this transient system, linear PCR products corresponding to the genes for the sgRNA and Cas9, and lacking a selection marker, were cotransformed into cells along with the selectable repair template [<xref rid="ppat.1006209.ref010" ref-type="bibr">10</xref>]. The linear PCR products apparently functioned, as indicated by the frequency of mutant recovery, but were not maintained in the genome [<xref rid="ppat.1006209.ref010" ref-type="bibr">10</xref>]. These transient systems may become popular for fungal pathogen genome engineering because of their simplicity, requiring only PCR and no cloning.</p></sec><sec id="sec003"><title>On the near horizon</title><p>Some of the most burning questions in the field of genome editing have to do with off-target effects [<xref rid="ppat.1006209.ref001" ref-type="bibr">1</xref>,<xref rid="ppat.1006209.ref016" ref-type="bibr">16</xref>]: How can off-target effects be assessed? How can they be minimized? Many off-target sites in other systems have one or a few mismatches to the sgRNA, particularly in its 5&#x02032; region, so mutations in candidate off-target sites may be tested through sequencing or nuclease-based assays [<xref rid="ppat.1006209.ref016" ref-type="bibr">16</xref>]. The capture of break sites for sequencing or whole-genome sequencing are also useful approaches [<xref rid="ppat.1006209.ref016" ref-type="bibr">16</xref>]. Technologies to minimize off-target effects are now maturing. For example, the use of paired Cas9 mutants that nick only a single strand can improve specificity considerably [<xref rid="ppat.1006209.ref017" ref-type="bibr">17</xref>], and high-specificity Cas9 variants have been engineered recently [<xref rid="ppat.1006209.ref018" ref-type="bibr">18</xref>]. Alternatively, use of 5&#x02032;-truncated sgRNAs has been shown to improve cleavage site specificity [<xref rid="ppat.1006209.ref019" ref-type="bibr">19</xref>]. It is encouraging that a 5&#x02032;-truncated sgRNA has been shown to function for on-target effects in <italic>A</italic>. <italic>fumigatus</italic> [<xref rid="ppat.1006209.ref007" ref-type="bibr">7</xref>]. However, there have been few assessments of off-target effects in the human fungal pathogens. Interestingly, this field has a long-standing tradition of concern about secondary mutations and their phenotypic impact. Investigators have addressed this concern through analysis of complemented derivatives of mutant strains. Thus far, only one Cas9-sgRNA&#x02014;directed mutation in a human fungal pathogen has been subjected to validation through complementation [<xref rid="ppat.1006209.ref008" ref-type="bibr">8</xref>]. To be fair, the test loci used for development of Cas9-sgRNA systems have been well characterized previously, and the newly created Cas9-sgRNA&#x02014;directed mutations generally have the expected phenotypes. However, the development of facile complementation or gene-reconstitution systems to accompany genome editing technology will be critical to address newly accessible questions about gene functions and interactions.</p><p>There is also a long-standing question in the fungal pathogen field that is now more accessible than ever: how universal are the virulence and drug resistance determinants defined through genetic manipulation? Most gene function studies thus far have focused on one or two isolates of a pathogen that are amenable to genetic analysis. Yet there are many examples in which detailed analysis of a new clinical isolate can break ground in our broader understanding of pathogen biology and drug resistance [<xref rid="ppat.1006209.ref020" ref-type="bibr">20</xref>,<xref rid="ppat.1006209.ref021" ref-type="bibr">21</xref>,<xref rid="ppat.1006209.ref022" ref-type="bibr">22</xref>,<xref rid="ppat.1006209.ref023" ref-type="bibr">23</xref>]. Perhaps the most important lesson from the genome editing field is that the breadth of strains and species that can be subjected to targeted genome modification is nothing short of incredible! One exciting opportunity on the horizon, illustrated in the study of Vyas et al. [<xref rid="ppat.1006209.ref011" ref-type="bibr">11</xref>], is to validate prospective drug targets and explore pathogenesis mechanisms in a range of clinical isolates of the major human fungal pathogens.</p></sec></body><back><ack><p>I thank Manning Huang, Katherine Lagree, and Carol A. Woolford for many intriguing discussions and for their comments on this manuscript. I am also grateful to Frederick Lanni, Scott G. Filler, and the students in my Genome Editing Biotechnology class for many exciting CRISPR-inspired discussions.</p></ack><ref-list><title>References</title><ref id="ppat.1006209.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Sternberg</surname><given-names>SH</given-names></name>, <name><surname>Doudna</surname><given-names>JA</given-names></name> (<year>2015</year>) <article-title>Expanding the Biologist's Toolkit with CRISPR-Cas9</article-title>. <source>Mol Cell</source>
<volume>58</volume>: <fpage>568</fpage>&#x02013;<lpage>574</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2015.02.032</pub-id>
<?supplied-pmid 26000842?><pub-id pub-id-type="pmid">26000842</pub-id></mixed-citation></ref><ref id="ppat.1006209.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Jasin</surname><given-names>M</given-names></name>, <name><surname>Haber</surname><given-names>JE</given-names></name> (<year>2016</year>) <article-title>The democratization of gene editing: Insights from site-specific cleavage and double-strand break repair</article-title>. <source>DNA Repair (Amst)</source>
<volume>44</volume>: <fpage>6</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="pmid">27261202</pub-id></mixed-citation></ref><ref id="ppat.1006209.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Krappmann</surname><given-names>S</given-names></name> (<year>2017</year>) <article-title>CRISPR-Cas9, the new kid on the block of fungal molecular biology</article-title>. <source>Med Mycol</source>
<volume>55</volume>: <fpage>16</fpage>&#x02013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1093/mmy/myw097</pub-id>
<?supplied-pmid 27811178?><pub-id pub-id-type="pmid">27811178</pub-id></mixed-citation></ref><ref id="ppat.1006209.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>DiCarlo</surname><given-names>JE</given-names></name>, <name><surname>Norville</surname><given-names>JE</given-names></name>, <name><surname>Mali</surname><given-names>P</given-names></name>, <name><surname>Rios</surname><given-names>X</given-names></name>, <name><surname>Aach</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems</article-title>. <source>Nucleic Acids Res</source>
<volume>41</volume>: <fpage>4336</fpage>&#x02013;<lpage>4343</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkt135</pub-id>
<?supplied-pmid 23460208?><pub-id pub-id-type="pmid">23460208</pub-id></mixed-citation></ref><ref id="ppat.1006209.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Nodvig</surname><given-names>CS</given-names></name>, <name><surname>Nielsen</surname><given-names>JB</given-names></name>, <name><surname>Kogle</surname><given-names>ME</given-names></name>, <name><surname>Mortensen</surname><given-names>UH</given-names></name> (<year>2015</year>) <article-title>A CRISPR-Cas9 System for Genetic Engineering of Filamentous Fungi</article-title>. <source>PLoS ONE</source>
<volume>10</volume>: <fpage>e0133085</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0133085</pub-id>
<?supplied-pmid 26177455?><pub-id pub-id-type="pmid">26177455</pub-id></mixed-citation></ref><ref id="ppat.1006209.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Fuller</surname><given-names>KK</given-names></name>, <name><surname>Chen</surname><given-names>S</given-names></name>, <name><surname>Loros</surname><given-names>JJ</given-names></name>, <name><surname>Dunlap</surname><given-names>JC</given-names></name> (<year>2015</year>) <article-title>Development of the CRISPR/Cas9 System for Targeted Gene Disruption in Aspergillus fumigatus</article-title>. <source>Eukaryot Cell</source>
<volume>14</volume>: <fpage>1073</fpage>&#x02013;<lpage>1080</lpage>. <pub-id pub-id-type="doi">10.1128/EC.00107-15</pub-id>
<?supplied-pmid 26318395?><pub-id pub-id-type="pmid">26318395</pub-id></mixed-citation></ref><ref id="ppat.1006209.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>C</given-names></name>, <name><surname>Meng</surname><given-names>X</given-names></name>, <name><surname>Wei</surname><given-names>X</given-names></name>, <name><surname>Lu</surname><given-names>L</given-names></name> (<year>2016</year>) <article-title>Highly efficient CRISPR mutagenesis by microhomology-mediated end joining in Aspergillus fumigatus</article-title>. <source>Fungal Genet Biol</source>
<volume>86</volume>: <fpage>47</fpage>&#x02013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1016/j.fgb.2015.12.007</pub-id>
<?supplied-pmid 26701308?><pub-id pub-id-type="pmid">26701308</pub-id></mixed-citation></ref><ref id="ppat.1006209.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Wei</surname><given-names>D</given-names></name>, <name><surname>Zhu</surname><given-names>X</given-names></name>, <name><surname>Pan</surname><given-names>J</given-names></name>, <name><surname>Zhang</surname><given-names>P</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>A 'suicide' CRISPR-Cas9 system to promote gene deletion and restoration by electroporation in Cryptococcus neoformans</article-title>. <source>Sci Rep</source>
<volume>6</volume>: <fpage>31145</fpage>
<pub-id pub-id-type="doi">10.1038/srep31145</pub-id>
<?supplied-pmid 27503169?><pub-id pub-id-type="pmid">27503169</pub-id></mixed-citation></ref><ref id="ppat.1006209.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Arras</surname><given-names>SD</given-names></name>, <name><surname>Chua</surname><given-names>SM</given-names></name>, <name><surname>Wizrah</surname><given-names>MS</given-names></name>, <name><surname>Faint</surname><given-names>JA</given-names></name>, <name><surname>Yap</surname><given-names>AS</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>Targeted Genome Editing via CRISPR in the Pathogen Cryptococcus neoformans</article-title>. <source>PLoS ONE</source>
<volume>11</volume>: <fpage>e0164322</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0164322</pub-id>
<?supplied-pmid 27711143?><pub-id pub-id-type="pmid">27711143</pub-id></mixed-citation></ref><ref id="ppat.1006209.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Min</surname><given-names>K</given-names></name>, <name><surname>Ichikawa</surname><given-names>Y</given-names></name>, <name><surname>Woolford</surname><given-names>CA</given-names></name>, <name><surname>Mitchell</surname><given-names>AP</given-names></name> (<year>2016</year>) <article-title>Candida albicans Gene Deletion with a Transient CRISPR-Cas9 System</article-title>. <source>mSphere</source>
<volume>1</volume>.</mixed-citation></ref><ref id="ppat.1006209.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Vyas</surname><given-names>VK</given-names></name>, <name><surname>Barrasa</surname><given-names>MI</given-names></name>, <name><surname>Fink</surname><given-names>GR</given-names></name> (<year>2015</year>) <article-title>A Candida albicans CRISPR system permits genetic engineering of essential genes and gene families</article-title>. <source>Sci Adv</source>
<volume>1</volume>: <fpage>e1500248</fpage>
<pub-id pub-id-type="doi">10.1126/sciadv.1500248</pub-id>
<?supplied-pmid 25977940?><pub-id pub-id-type="pmid">25977940</pub-id></mixed-citation></ref><ref id="ppat.1006209.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Enkler</surname><given-names>L</given-names></name>, <name><surname>Richer</surname><given-names>D</given-names></name>, <name><surname>Marchand</surname><given-names>AL</given-names></name>, <name><surname>Ferrandon</surname><given-names>D</given-names></name>, <name><surname>Jossinet</surname><given-names>F</given-names></name> (<year>2016</year>) <article-title>Genome engineering in the yeast pathogen Candida glabrata using the CRISPR-Cas9 system</article-title>. <source>Sci Rep</source>
<volume>6</volume>: <fpage>35766</fpage>
<pub-id pub-id-type="doi">10.1038/srep35766</pub-id>
<?supplied-pmid 27767081?><pub-id pub-id-type="pmid">27767081</pub-id></mixed-citation></ref><ref id="ppat.1006209.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Mali</surname><given-names>P</given-names></name>, <name><surname>Yang</surname><given-names>L</given-names></name>, <name><surname>Esvelt</surname><given-names>KM</given-names></name>, <name><surname>Aach</surname><given-names>J</given-names></name>, <name><surname>Guell</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>RNA-guided human genome engineering via Cas9</article-title>. <source>Science</source>
<volume>339</volume>: <fpage>823</fpage>&#x02013;<lpage>826</lpage>. <pub-id pub-id-type="doi">10.1126/science.1232033</pub-id>
<?supplied-pmid 23287722?><pub-id pub-id-type="pmid">23287722</pub-id></mixed-citation></ref><ref id="ppat.1006209.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Gao</surname><given-names>Y</given-names></name>, <name><surname>Zhao</surname><given-names>Y</given-names></name> (<year>2014</year>) <article-title>Self-processing of ribozyme-flanked RNAs into guide RNAs in vitro and in vivo for CRISPR-mediated genome editing</article-title>. <source>J Integr Plant Biol</source>
<volume>56</volume>: <fpage>343</fpage>&#x02013;<lpage>349</lpage>. <pub-id pub-id-type="doi">10.1111/jipb.12152</pub-id>
<?supplied-pmid 24373158?><pub-id pub-id-type="pmid">24373158</pub-id></mixed-citation></ref><ref id="ppat.1006209.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Thomas</surname><given-names>KR</given-names></name>, <name><surname>Folger</surname><given-names>KR</given-names></name>, <name><surname>Capecchi</surname><given-names>MR</given-names></name> (<year>1986</year>) <article-title>High frequency targeting of genes to specific sites in the mammalian genome</article-title>. <source>Cell</source>
<volume>44</volume>: <fpage>419</fpage>&#x02013;<lpage>428</lpage>. <?supplied-pmid 3002636?><pub-id pub-id-type="pmid">3002636</pub-id></mixed-citation></ref><ref id="ppat.1006209.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>X</given-names></name>, <name><surname>Kriz</surname><given-names>AJ</given-names></name>, <name><surname>Sharp</surname><given-names>PA</given-names></name> (<year>2014</year>) <article-title>Target specificity of the CRISPR-Cas9 system</article-title>. <source>Quant Biol</source>
<volume>2</volume>: <fpage>59</fpage>&#x02013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1007/s40484-014-0030-x</pub-id>
<?supplied-pmid 25722925?><pub-id pub-id-type="pmid">25722925</pub-id></mixed-citation></ref><ref id="ppat.1006209.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Ran</surname><given-names>FA</given-names></name>, <name><surname>Hsu</surname><given-names>PD</given-names></name>, <name><surname>Lin</surname><given-names>CY</given-names></name>, <name><surname>Gootenberg</surname><given-names>JS</given-names></name>, <name><surname>Konermann</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity</article-title>. <source>Cell</source>
<volume>154</volume>: <fpage>1380</fpage>&#x02013;<lpage>1389</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2013.08.021</pub-id>
<?supplied-pmid 23992846?><pub-id pub-id-type="pmid">23992846</pub-id></mixed-citation></ref><ref id="ppat.1006209.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Slaymaker</surname><given-names>IM</given-names></name>, <name><surname>Gao</surname><given-names>L</given-names></name>, <name><surname>Zetsche</surname><given-names>B</given-names></name>, <name><surname>Scott</surname><given-names>DA</given-names></name>, <name><surname>Yan</surname><given-names>WX</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>Rationally engineered Cas9 nucleases with improved specificity</article-title>. <source>Science</source>
<volume>351</volume>: <fpage>84</fpage>&#x02013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1126/science.aad5227</pub-id>
<?supplied-pmid 26628643?><pub-id pub-id-type="pmid">26628643</pub-id></mixed-citation></ref><ref id="ppat.1006209.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Fu</surname><given-names>Y</given-names></name>, <name><surname>Sander</surname><given-names>JD</given-names></name>, <name><surname>Reyon</surname><given-names>D</given-names></name>, <name><surname>Cascio</surname><given-names>VM</given-names></name>, <name><surname>Joung</surname><given-names>JK</given-names></name> (<year>2014</year>) <article-title>Improving CRISPR-Cas nuclease specificity using truncated guide RNAs</article-title>. <source>Nat Biotechnol</source>
<volume>32</volume>: <fpage>279</fpage>&#x02013;<lpage>284</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.2808</pub-id>
<?supplied-pmid 24463574?><pub-id pub-id-type="pmid">24463574</pub-id></mixed-citation></ref><ref id="ppat.1006209.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Selmecki</surname><given-names>A</given-names></name>, <name><surname>Forche</surname><given-names>A</given-names></name>, <name><surname>Berman</surname><given-names>J</given-names></name> (<year>2006</year>) <article-title>Aneuploidy and isochromosome formation in drug-resistant Candida albicans</article-title>. <source>Science</source>
<volume>313</volume>: <fpage>367</fpage>&#x02013;<lpage>370</lpage>. <pub-id pub-id-type="doi">10.1126/science.1128242</pub-id>
<?supplied-pmid 16857942?><pub-id pub-id-type="pmid">16857942</pub-id></mixed-citation></ref><ref id="ppat.1006209.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Sasse</surname><given-names>C</given-names></name>, <name><surname>Dunkel</surname><given-names>N</given-names></name>, <name><surname>Schafer</surname><given-names>T</given-names></name>, <name><surname>Schneider</surname><given-names>S</given-names></name>, <name><surname>Dierolf</surname><given-names>F</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>The stepwise acquisition of fluconazole resistance mutations causes a gradual loss of fitness in Candida albicans</article-title>. <source>Mol Microbiol</source>
<volume>86</volume>: <fpage>539</fpage>&#x02013;<lpage>556</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2958.2012.08210.x</pub-id>
<?supplied-pmid 22924823?><pub-id pub-id-type="pmid">22924823</pub-id></mixed-citation></ref><ref id="ppat.1006209.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Slutsky</surname><given-names>B</given-names></name>, <name><surname>Buffo</surname><given-names>J</given-names></name>, <name><surname>Soll</surname><given-names>DR</given-names></name> (<year>1985</year>) <article-title>High-frequency switching of colony morphology in Candida albicans</article-title>. <source>Science</source>
<volume>230</volume>: <fpage>666</fpage>&#x02013;<lpage>669</lpage>. <?supplied-pmid 3901258?><pub-id pub-id-type="pmid">3901258</pub-id></mixed-citation></ref><ref id="ppat.1006209.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Hirakawa</surname><given-names>MP</given-names></name>, <name><surname>Martinez</surname><given-names>DA</given-names></name>, <name><surname>Sakthikumar</surname><given-names>S</given-names></name>, <name><surname>Anderson</surname><given-names>MZ</given-names></name>, <name><surname>Berlin</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Genetic and phenotypic intra-species variation in Candida albicans</article-title>. <source>Genome Res</source>
<volume>25</volume>: <fpage>413</fpage>&#x02013;<lpage>425</lpage>. <pub-id pub-id-type="doi">10.1101/gr.174623.114</pub-id>
<?supplied-pmid 25504520?><pub-id pub-id-type="pmid">25504520</pub-id></mixed-citation></ref></ref-list></back></article>